Turning the Spotlight on Cancers of the Hepatobiliary System

Bile duct cancer and other biliary system cancers are among the most difficult to detect. The Bili Project aims to create a bank of Hepatobiliary tumor specimens at UCSF to advance research. Read More

We Bilieve in Early Detection

Learn to recognize the warning signs and symptoms which sometimes resembles other medical conditions or problems. Hepatobiliary cancers are the 7th leading cause of cancer death within the United State and the 3rd leading cause of cancer death worldwide. Know the Signs

Bilievers Wanted!

Support The Bili Project so you don't have to lose a love one to this silent killer. There are many ways you can get involved and make a difference with The Bili Project Foundation. You can donate, volunteer your time, share your story or even suggest an event. Get Involved

The Bili Project is a Hepatobiliary Cancer Awareness and Research Program. It's mission is to reduce the incidence and improve the outcomes of Hepatobiliary cancers by promoting research to identify biomarkers and therapeutic targets.

Clinical Trials

Clinical Trials & Research Studies

The Bili Project Clinical Trial Navigation Service through EmergingMed provides the most up-to-date list of clinical trials available for hepatobiliary cancers. We are hopeful that these research efforts will provide the groundwork for positive outcomes for patients suffering from these cancers.


Bili Connect

Online Patient Community

The Bili CancerConnect Community is for everyone whose life has been touched by cancer. It is a place where you can safely voice your ideas, thoughts, and concerns; benefit from the experience of others; and most importantly, realize you don’t have to feel alone. This community is for and about you.



Stay Informed with The Bili Project

The Bili Project aims to provide you with the latest in news, articles and education about the risks and symptoms of Hepatobiliary cancer and what is being done to improve and shed light on this complex group of diseases .